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A B S T R A C T
Damage to renal tubular and mesangial cells is central to the development of diabetic nephropathy (DN), a
complication of diabetes which can lead to renal failure. Mitochondria are the site of cellular respiration and
produce energy in the form of ATP via oxidative phosphorylation, and mitochondrial dysfunction has been
implicated in DN. Since the kidney is an organ with high bioenergetic needs, we postulated that hyperglycemia
causes damage to renal mitochondria resulting in bioenergetic deﬁcit. The bioenergetic proﬁles and the eﬀect of
hyperglycemia on cellular respiration of human primary mesangial (HMCs) and proximal tubular cells (HK-2)
were compared in normoglycemic and hyperglycemic conditions using the seahorse bio-analyzer. In
normoglycemia, HK-2 had signiﬁcantly lower basal, ATP-linked and maximal respiration rates, and lower
reserve capacity compared to HMCs. Hyperglycemia caused a down-regulation of all respiratory parameters
within 4 days in HK-2 but not in HMCs. After 8 days of hyperglycemia, down-regulation of respiratory
parameters persisted in tubular cells with compensatory up-regulated glycolysis. HMCs had reduced maximal
respiration and reserve capacity at 8 days, and by 12 days had compromised mitochondrial respiration despite
which they did not enhance glycolysis. These data suggest that diabetes is likely to lead to a cellular deﬁcit in
ATP production in both cell types, although with diﬀerent sensitivities, and this mechanism could signiﬁcantly
contribute to the cellular damage seen in the diabetic kidney. Prevention of diabetes induced damage to renal
mitochondrial respiration may be a novel therapeutic approach for the prevention/treatment of DN.
1. Introduction
Diabetic nephropathy (DN) is a kidney disease which aﬀects
approximately one-third of patients with diabetes and develops over
a long period of clinical silence [1]. Despite good metabolic control,
patients with both Type 1 and Type 2 diabetes are at risk of DN [2–4].
With the epidemic rise in the incidence of diabetes currently aﬀecting
more 350 million people worldwide, more than 100 million people are
at risk of DN and approximately 30% of these are likely to progress to
end stage renal failure despite therapy [5,6]. Therefore, there is an
urgent need to understand the underlying mechanisms that result in
damage to the kidney in order to design novel preventative and
therapeutic strategies.
DN is associated with structural changes in the kidney manifested
as thickening of the glomerular basement membrane and expansion of
the extracellular matrix (ECM) with deposition of collagen type IV and
VI, ﬁbronectin and laminin [7], resulting in glomerulosclerosis and
tubular interstitial ﬁbrosis, pathological hallmarks of DN. Mesangial
cells are specialised smooth muscle cells located around the glomerular
capillaries within the renal corpuscle of the kidney and have several
functions, including the deposition of ECM. In DN, mesangial cells
contribute to the disease by responding to increased glomerular
ﬁltration pressure by the expansion of the matrix into the capillary
lumens and the secretion of pro-inﬂammatory cytokines [8], leading to
glomerulosclerosis and glomerular inﬂammation [9]. Although, for a
long time the major pathogenic mechanisms in DN were thought to
stem from glomerulosclerosis through mesangial expansion, it is now
widely accepted that tubular epithelial cells present in the lining of the
nephrons are also involved and contribute to interstitial ﬁbrosis,
peritubular capillary loss and destruction of functioning nephrons
due to tubular atrophy and severe tubulointerstitial lesions [10–13].
Hyperglycemia is known to be a contributing factor in the devel-
opment of DN through activation of a series of overlapping biochemical
pathways [14]. Hyperglycemia-induced oxidative stress caused by the
over-production of mitochondrial reactive oxygen species (ROS) has
been implicated in this process [15,16]. Indirect evidence for mito-
chondrial involvement in DN from animal and in-vitro studies has been
accumulating [17–20] and more recently, studies have directly demon-
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strated mitochondrial dysfunction in human clinical samples. For
example Sharma et al., demonstrated that patients with DN had
reduced urinary mitochondrial metabolites [21]. We recently reported
that mitochondrial DNA and mitochondrial RNAs are altered in blood
cells of DN patients, and in renal cells cultured in high glucose [22].
Despite the putative involvement of mitochondrial dysfunction in DN,
the exact mechanisms involved remain unknown [17].
Kidneys are organs requiring large amounts of energy in form of
ATP due to the re-absorption processes and although their mass
accounts for less than 1% of total body mass, they use almost 10% of
the body's oxygen which is utilized in cellular respiration [23]. Renal
mRNA proﬁling shows one of the highest levels of mitochondrial
transcripts, after colon, muscle and heart [24], suggesting an abun-
dance of renal mitochondria. In support of this, we recently showed
that mouse kidneys have one of the highest amount of MtDNA, second
only to the heart, when compared to liver, lung, brain, islet and blood
[25]. Eukaryotic cells, especially those with high energy demands like
kidney cells, rely mostly on ATP generated through oxidative phos-
phorylation (OXPHOS), which is 15 times more productive than the
amount produced by aerobic glycolysis [26]. OXPHOS takes place in
the electron transport chain (ETC) located within the mitochondrial
matrix and can be studied by precise measurement of oxygen con-
sumption rate and proton leak, a process described as extracellular ﬂux
analysis, which can be used to deﬁne the bioenergetic properties of cells
[27–29]. The use of speciﬁc inhibitors of various part of the ETC, which
is made of 5 complexes of proteins, allows the deﬁnition of cellular
bioenergetic proﬁles [30] and can provide information on cellular
metabolism.
There have been very few studies of mitochondrial bioenergetics
related to DN. We recently reported for the ﬁrst time that peripheral
blood mononuclear cells (PBMCs) from patients with DN have a
severely diminished bioenergetic proﬁle and reduced reserve capacity
when compared to diabetes controls, the latter had a long duration of
diabetes and no history of kidney disease [22]. This deﬁcit could
contribute to energy depletion, and indeed we found that mesangial
cells grown in diabetic conditions show altered mitochondrial respira-
tion [22]. Therefore, in the current study, we wished to test the
hypothesis that diabetes can cause damage to mitochondrial respira-
tion in kidney cells and to examine respiration in the two key cell types
known to be implicated in DN, namely tubular and mesangial cells.
2. Materials and methods
2.1. Human mesangial and tubular cells
Primary human mesangial cells (HMCs) were cultured and char-
acterised as previously described [31,32] and grown in Dulbecco's
Modiﬁed Eagle Medium (DMEM, Sigma Aldrich) supplemented with
10% FBS, ITS and antibiotics. Human cortex proximal tubular
immortalized cells (HK-2, ATCC, LGC Standards) were cultured
according to the manufacturer's conditions. Cells were seeded at an
equal density (1×105/well) in DMEM containing either 5 mM (normal,
NG) or 25 mM (high, HG) glucose for 4 and 8 days. 20 mMmannitol in
5 mM glucose DMEM was used as an osmotic control in all experi-
ments.
2.2. Extracellular ﬂux analysis
The metabolic proﬁles of cultured HMCs and HK-2 cells were
assessed using the XFe96 Seahorse analyser and XF cell mito stress test
kit and XF-FluxPaks containing 96-well plates and cartridges (Agilent
Technologies).
Oxygen consumption rate (OCR), a measurement of mitochondrial
respiration, and extracellular acidiﬁcation rate (ECAR), were deter-
mined in the presence of speciﬁc mitochondrial activators and inhibi-
tors. Oligomycin (ATP synthase blocker) was used to measure ATP
turnover and to determine proton leak. Mitochondrial un-coupler
FCCP (carbonyl cyanide 4-[triﬂuoromethoxy] phenylhydrazone) was
used to measure maximum respiratory function (maximal OCR).
Reserve capacity was calculated as a maximal OCR minus the basal
respiration. Rotenone (inhibitor of complex I) and antimycin A (a
blocker of complex III), were injected to completely shut the mitochon-
drial respiration down, to conﬁrm that any observed changes in
respiration were mitochondrial [33,34]. In order to determine optimal
cell number and drug concentration, optimisation experiments with a
diﬀerent cell seeding number and titration of electron transport chain
activators and inhibitors were carried out, to accurately assess OCR and
ECAR as described by Dranka et al. [33].
One day prior to the extracellular ﬂux measurement, HMCs and
HK-2 cells were seeded at the concentration of 30,000 and 25,000 cells
per well respectively in 96-well assay plates in complete growth
medium containing 5 mm, 25 mM glucose and osmotic control. 1hr
prior to the experiment the growth medium was removed, cells were
washed 3 times and then incubated in low buﬀered assay medium
(Agilent Technologies) supplemented with 5 mM glucose and 1 mM
sodium pyruvate, pH 7.4. The microplates were then assayed in the
XFe96 analyzer. For a measurement of steady basal respiration, 4–5
measurements were taken before injecting ATP synthase inhibitor,
oligomycin at 1 μM (ﬁnal concentration). Mitochondrial membrane
uncoupler FCCP was then injected at 0.75 μM. Finally a mixture of
rotenone and antimycin A (1 μM) was injected. Mitochondrial basal
respiration, proton leak, spare capacity and maximal respiration were
measured after correcting for non-mitochondrial respiration. After
ﬁnishing the experiments 20 μl of cell lysis buﬀer [33] were added
per well and protein content measured by a BCA assay (Fisher
Scientiﬁc). OCR and ECAR rates were normalized to the protein
content and presented as pmolesO2/min/μg protein and mpH/min/
μg protein respectively.
2.3. Statistics
Analysis was performed using GraphPad (GraphPad Software, Inc).
The distribution of the data was tested using the Kolmogorov-Smirnov
test and histograms and parametric tests were used on raw data.
Groups were compared using Student's t-test (2 groups) or one way
ANOVA with post-hoc Tukey's multiple comparison test ( > 2 groups),
statistical signiﬁcance was considered at P < 0.05. Data are presented
as mean ± SEM.
3. Results
3.1. Cellular bioenergetics of renal mesangial and tubular cells
We ﬁrst characterised the bioenergetic proﬁles of mesangial
(HMCs) and tubular (HK-2 cells) in normoglycemic conditions
(5 mM glucose) using the seahorse XFe96analyser. Oxygen consump-
tion rate (OCR) including basal, ATP-linked, maximal respiration and
reserve capacity, and basal extracellular acidiﬁcation rate (ECAR)
which correlates to amount of protons released from the cell with
potential contribution from glycolysis and the Krebs cycle were
determined in real time (Fig. 1A-H) using speciﬁc activators and
inhibitors of cellular respiration [30].
HK-2 cells had signiﬁcantly lower (P < 0.001) levels of basal
respiration (13 pmolesO2/min/μg of protein) when compared to
HMCs (20 pmolesO2/min/μg of protein, Fig. 1A, 1H). Following the
injection of oligomycin, an ATP synthase inhibitor, basal OCR is
expected to drop and the level of drop can be used to deduce ATP-
production (ATP-linked respiration). ATP linked respiration was sig-
niﬁcantly lower (P < 0.001) in HK-2 cells (11 pmolesO2/min/μg pro-
tein) compared to HMCs (16 pmolesO2/min/μg of protein, Fig. 1B,
1H). Injection of mitochondrial uncoupler, FCCP caused an increase in
OCR and allowed measurement of the maximal mitochondrial respira-
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Fig. 1. The bioenergetic proﬁles of human mesangial and tubular cells. Human glomerular mesangial (HMCs) and tubular (HK-2) cells were grown in DMEM containing 5mM glucose
for 4 days and cellular bioenergetics was assessed: Four measurement of basal OCR were used to determine basal OCR (A); ATP- linked respiration (B) and proton leak (C) were
determined following the injection of oligomycin (1 μM ﬁnal); Maximal respiration (E) was determined after FCCP injection (0.3 μM); Reserve capacity was measured as the diﬀerence
between maximal and basal respiration (F); Coupling eﬃciency (I); Bioenergetic proﬁles of HMCs and HK-2 with parameters expressed as a % of the maximal respiration following FCCP
injection (J). All the parameters were calculated by subtracting non-mitochondrial values for each sample (D). Data shown as a mean ± SEM, n=7–14 replicates from 2 independent
experiments. Independent student’s t-test where, **P < 0.01, ***P < 0.001.
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tion and reserved capacity. Maximal OCR was signiﬁcantly lower (P <
0.01) in HK-2 cells (20 pmolesO2/min/μg of protein) compared to
HMCs (33 pmolesO2/min/μg of protein, Fig. 1E, 1H). Reserve capacity
was also signiﬁcantly lower (P < 0.01) in HK-2 cells (6.5 pmolesO2/
min/μg of protein) compared to HMCs (12 pmolesO2/min/μg of
protein, Fig. 1F).
Proton leak, measured as the diﬀerence between ATP-linked and
basal OCR, was signiﬁcantly lower (P < 0.001) in HK-2 cells
(2.2 pmolesO2/min/μg of protein) compared to HMCs
(4.5 pmolesO2/min/μg of protein, Fig. 1C). Non-mitochondrial re-
spiration, measured as a drop in OCR following the administration of
mitochondrial respiratory chain blockers, rotenone and antimycin A,
did not vary signiﬁcantly between the two cell types, and was measured
as 4.6 and 5.6 pmolesO2/min/μg of protein for HK-2 and HMCs
respectively (P > 0.05, Fig. 1D). Basal glycolytic rates were also
measured at similar levels between both experimental cell types (P >
0.05, Fig. 1G).
We next evaluated the coupling eﬃciency deﬁned as a proportion of
mitochondrial oxygen consumption used for the ATP synthesis
(Fig. 1I). Coupling eﬃciency represents the proportion of the substrate
oxidation energy used for the ATP production, while the rest is lost as a
heat. Of all the oxygen consumed, HK-2 cells use a signiﬁcantly higher
rate for ATP-linked respiration relative to HMCs (P < 0.05, 0.8 versus
0.75 respectively, Fig. 1I).
The proportional distribution of oxygen consumption and utiliza-
tion among the diﬀerent parameters deﬁned in the bioenergetic proﬁle
illustrate the higher reserve capacity but lower ATP-linked respiration
in HMCs compared to HK-2 cells (Fig. 1J).
3.2. Hyperglycemia induced alterations in cellular respiration in
renal tubular cells
The eﬀect of hyperglycemia on cellular respiration in HK-2 cells was
examined. Growth in high glucose caused a signiﬁcant down-regulation
of all respiratory parameters. Basal, ATP-linked and maximal respira-
tion as well as reserve capacity were reduced within four days (P <
0.01) and remained reduced after prolonged exposure over 8 days
(Fig. 2A, B, E, F). No signiﬁcant changes were detected in proton leak
(P > 0.05, Fig. 2C), but non-mitochondrial respiration was signiﬁcantly
reduced following growth in HG (P < 0.05, Fig. 2D). Basal ECAR was
signiﬁcantly up-regulated after 8 days growth in HG (P < 0.05, Fig. 2G).
HK-2 cells had signiﬁcantly down regulated metabolic rate (plotted
as a ration of OCR and ECAR) when cultured in HG for 4 and 8 days
and compared to NG controls (P < 0.001, P < 0.01 respectively Fig. 2I).
Mitochondrial respiration was unaltered in osmolarity controls and
was unaﬀected by the duration of culturing time (Supplementary Fig. 1
and Fig. 2) showing that the changes in respiration of tubular cells were
a direct consequence of growth in hyperglycemia.
3.3. Hyperglycemia induced changes in cellular respiration in renal
mesangial cells
Unlike tubular cells, growth of mesangial cells in HG for 4 days did
not aﬀect their bioenergetic proﬁles, there were no signiﬁcant changes
in basal, ATP-linked, maximal respiration, and basal glycolytic rate
remained unchanged (P > 0,05, Fig. 2A-E). Growth of mesangial cells
in HG for 8 days still did not aﬀect basal and ATP-linked respiration
and basal glycolytic rate (P > 0.05), however maximal OCR and reserve
capacity were reduced (P < 0.05, Fig. 2A-E and G). No statistically
signiﬁcant diﬀerence was detected in the non-mitochondrial respira-
tion (P > 0.05, Fig. 2F) and in basal glycolytic rate (P > 0.05, Fig. 2H).
The metabolic rates of mesangial cells were plotted as the ratio of
OCR and ECAR under basal conditions and were unaltered in
hyperglycemic conditions (P > 0.05, Fig. 2I). Mitochondrial respiration
was unaltered in osmolarity controls and was unaﬀected by duration of
culturing time of mesangial cells (Supplementary Fig. 1 and Fig. 2).
Since HMCs seemed more resistant to hyperglycemia than HK-2
cells, we decided to determine the eﬀect of longer exposure to
hyperglycemia, therefore HMCs were cultured for 12 days in normal
and HG (Fig. 3). 12-d exposure to HG decreased basal oxygen
consumption rate in HMCs by more than 50% when compared to
control (P < 0.0001, Fig. 3A) and the respiration used for the ATP
production reduced by 2.5 fold when compared to cells cultured in NG
(P < 0.0001, Fig. 3A). There was no diﬀerence in proton leak and in
non-mitochondrial respiration (P > 0.05, data not shown). As described
above, maximal respiratory capacity of cells, was signiﬁcantly lower in
the cells cultured for 8 days in HG when compared to the controls, and
this reduction became highly signiﬁcant (P < 0.0001) after 12 days of
culture in HG, with 3 fold reduction of maximal OCR (P < 0.0001,
Fig. 3A) and 4 fold reduction in the reserve capacity when compared to
cells cultured in NG (P < 0.001). When glycolysis was assessed in these
cells, there was also a signiﬁcant reduction in glycolysis at basal level
(P < 0.05) and also after the addition of oligomycin (which stimulates
glycolysis due to inhibition of ATP synthesis, P < 0.01, Fig. 3B).
Furthermore, we found that the ability of cells to respond to acute
stress was also blunted after 12 days growth in hyperglycemic condi-
tions (Fig. 4). HMCs grown in normoglycemic conditions for 12 days
were able to respond to acute stress by altering their metabolism,
whereas the hyperglycemic cells had lost this ability (Fig. 4). After acute
glucose load, both normoglycemic and hyperglycemia HMCs switched
their metabolism to glycolysis (Fig. 4), however hyperglycemic HMCs
which were previously exposed to chronic hyperglycemia had lost their
ﬂexibility to respond to nutrient load, as they could not increase their
glycolytic rate but at the same time mitochondrial respiration remained
the same which suggested they cannot balance their energy production.
In summary, we showed that 4 days exposure to hyperglycemia had
no eﬀect on any of the measured parameters involved in mitochondrial
respiration or glycolysis in HMCs, 8 days exposure signiﬁcantly
decreased maximal respiration and reserve capacity but did not aﬀect
any other mitochondrial respiration parameters, whereas 12 days
exposure signiﬁcantly diminished both mitochondrial respiration and
glycolytic capacity, suggesting an energy deﬁcit in these cells.
4. Discussion
With the global rise in the incidence of diabetes, diabetic nephro-
pathy, a major risk factor for morbidity and mortality, is likely to reach
epidemic levels in the next decade. To combat this, there is a strong
clinical need to understand the early molecular mechanisms that lead
to kidney damage in diabetes. The kidney as an organ has a high
requirement for energy in the form of ATP derived from cellular
respiration to drive cellular processes [23,24]. Pathological changes in
renal mesangial and tubular cells are well known to play signiﬁcant
roles in the development and progression of DN and lead to glomer-
ulosclerosis and tubulointerstitial ﬁbrosis [10,12], both structural
hallmarks of DN, but the role of energy deﬁcit in these processes has
been largely unaddressed in the past. Mitochondrial dysfunction in the
diabetic kidney disease is increasingly being seen as a key mechanism
in DN [21,22] leading us to speculate that damage to the cellular
respiratory apparatus in the diabetic kidney could lead to energy deﬁcit
and cellular damage. In order to shed light on the bioenergetic
properties of renal cells, in the current paper we sought to deﬁne the
bioenergetic proﬁles of renal mesangial and tubular cells and to assess
whether diabetes can damage cellular respiration in these cells.
Cells need the ability to produce suﬃcient energy to carry out their
normal cellular function, and have diﬀering bioenergetic requirements
depending on their function. In addition, cells also have to be able to
respond to stressors by appropriately altering their metabolism. Our
data show that both HMCs and HK-2 cells have distinct metabolic
proﬁles and both cell types utilize more than two thirds of the
consumed oxygen into ATP production. HMCs’ mitochondrial respira-
tory parameters are much higher when compared to HK-2 cells in
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Fig. 2. Bioenergetic proﬁle of human kidney cells exposed to hyperglycemia. Human mesangial (HMCs) and tubular (HK-2) cells were grown in DMEM containing normal (5 mM)
glucose (NG), and high (25 mM) glucose (HG), and in osmolarity controls using mannitol (data not shown) for 4 and 8 days. One day prior to the assessment, cells were trypsinised,
counted and seeded at density of 25-30,000 cells/well. Oxygen consumption rate (OCR) was assessed using the Seahorse analyser: Four measurement of basal OCR were used to
determine basal OCR (A); ATP- linked respiration (B) and proton leak (C) were measured after oligomycin injection (1 μM ﬁnal concentration); Maximal respiration (E) was determined
after FCCP injection (0.3 μM); Reserve capacity was the diﬀerence between maximal and basal respiration (F); Extracellular acidiﬁcation rate (ECAR) representing glycolysis is shown on
ﬁgure G; Metabolic rates were expressed as the ratio of basal OCR and ECAR (H). All parameters were calculated by subtracting non-mitochondrial values for each sample (D). Data
shown as a mean ± SEM, n=7–17 replicates from 2 independent experiments. Independent student’s t-test where, *P < 0.05, ***P < 0.001.
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normoglycemia, but tubular cells’ coupling eﬃciency is signiﬁcantly
higher, meaning that of all the oxygen consumed, HK-2 cells use a
slightly higher proportion for ATP-linked respiration relative to HMCs
and lose less energy through proton leak.
The bioenergetic proﬁle of both mesangial and tubular cells was
negatively aﬀected by exposure to hyperglycemia but tubular cells were
more susceptible, with cellular respiration parameters being signiﬁ-
cantly altered within 4 days of exposure to high glucose, and showing
severe damage to cellular respiration by 8 days. In contrast, mesangial
cells showed little change in high glucose even after 8 days. After
prolonged high glucose exposure of 12 days, mesangial cells showed
signs of decreased mitochondrial respiratory function, reduced their
reserve capacity. Hyperglycemia had no eﬀect on the proton leak in
HMCs and HK-2, but tubular cells had decreased non-mitochondrial
respiration when exposed to high glucose. Therefore our data show that
cellular respiration is reduced in renal cells after exposure to hyper-
glycemia, and that mesangial cells are more resistant to this damage
than tubular cells but do become damaged and more sensitive to acute
stress after prolonged exposure.
Whilst mitochondrial and glycolytic metabolism have been pro-
posed to be altered in metabolic disease [35], few studies have
examined the eﬀect of hyperglycemia on these parameters.
Hyperglycemia has been previously shown to have varying eﬀects on
bioenergetics and cellular respiration in cultured cells, including
decreased, unaltered and increased cellular respiration. For example,
a decline in mitochondrial basal and maximal respiration was seen in
rat retinal endothelial cells after 3 and 6 days of culture [36], and
down-regulation of mitochondrial function (including reduced ATP-
linked respiration and reserve capacity) was seen in primary cultured
mouse mesangial cells exposed to hyperglycemia for 14 days [38], in
human mesangial cells after 8 days [22]. A faulty bioenergetic proﬁle
was observed in cultured neurons derived from streptozotocin induced
diabetic rats with decreased maximal respiration and decreased spare
capacity [39]. No changes in respiration were detected in bovine aortic
endothelial cells after 24 h exposure to hyperglycemia and in human
platelets cultured in high glucose for 18 h [37], interestingly these
studies had shorter duration of exposure to hyperglycemia than those
that observed decreases. In contrast, Stieger at al., (2012) demon-
strated an increase in the basal and maximal respiration of immorta-
lized mouse podocytes cultured in high glucose for 10 passages. [40].
Measurement of cellular respiration directly in live human blood cells
from patients with diabetes has also been attempted by us and others.
Increased mitochondrial basal, and maximal respiration rates were
found in peripheral blood mononuclear cells (PBMCs) from patients
with type 2 diabetes (T2D), when compared to healthy controls [41].
We previously found a slight but non-signiﬁcant increase in cellular
respiration in PBMCs from diabetes patients without complications
(both T1D and T2D) compared to healthy controls, however we found
that PBMCs of patients with DN had reduced reserve capacity and
increased sensitivity to stress, showing loss of metabolic ﬂexibility [22].
Mitochondrial respiration was also reported to be reduced in the
skeletal muscle of T2D patients [42,43] and not changed in myocytes
from non-diabetic, obese subjects with family history of T2D [44].
Using isolated mitochondria from diabetic models, Ruggiero at al.,
(2011) reported increased levels of mitochondrial superoxide dismu-
tase (MnSOD) and increased mitochondrial ATP-linked respiration in
Fig. 4. Prolonged exposure to hyperglycemia aﬀects the bioenergetic response to acute stress in mesangial cells. HMCs were grown in 5 mM (NG), 25 mM (HG) or osmolarity controls
for 12 days. One day prior to the assessment, cells were seeded at density of 35 000 cells/well in assay medium. Acute stress was induced by injection of 20 mM glucose (+) or normal
assay media (-) during the assessment in Seahorse analyzer. Oxygen consumption rates (OCR) (A) and extracellular acidiﬁcation rates (ECAR) (B) are shown for cells which has been
grown in normoglycemia (left panel) and cells which had been grown in hyperglycemic conditions (right panel) for 12 days. Data shown are mean values ± SEM, n=4-8 observations,
Student’s t-test where, ** P < 0.01, ***P < 0.001.
Fig. 3. Prolonged hyperglycemia aﬀects all bioenergetics parameters of human mesan-
gial cells. HMCs were grown in 5 mM (NG), 25 mM (HG), and osmolarity controls (not
shown) for 12 days. The day before the assessment, cells were trypsinized, counted and
seeded at density of 35,000 cells/well, and oxygen consumption rates (OCR) were
assessed in the Seahorse analyzer. (A) Four measurement of basal OCR were used to
determine basal OCR; ATP- linked respiration and proton leak were measured after
oligomycin injection (1 μM) and maximal respiration was determined after FCCP
injection (0.3 μM); Reserve capacity was the diﬀerence between maximal and basal
respiration; (B) Extracellular acidiﬁcation rates (ECAR) were used to represent glycolysis
and basal ECAR and ECAR after injection of the oligomycin (1 μM ﬁnal) are shown.
Values shown are mean ± SD, n=8 observations, Independent student’s t-test where, *P
< 0.05.
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12 week old diabetic animals, but this increase was not observed at
later stages, [45]. This suggests an adaptive response in mitochondrial
respiration in order to cope with nutrient overload, and an increase in
maximal and basal respiration which, when within threshold limit for
mitochondria without diminishing spare respiratory capacity may be
still tolerable. Longer exposure hyperglycemia might be detrimental as
we have previously demonstrated that hyperglycemia can also damage
MtDNA which could aﬀect mitochondrial function over time [22]. If
there is an adaptive phase when mitochondria increase their respira-
tion in response to nutrient overload, then this could contribute to
increased ROS production and further exacerbate cellular stress.
Anderson at al., (2009) reported increased mitochondrial H2O2 pro-
duction in human and rodent muscles fed with high fat diets, which
correlated with a shift in cellular redox balance, without any changes in
mitochondrial respiration. The oxidation state of the cells was balanced
following treatment with mitochondria-speciﬁc antioxidants [46].
The data from the current study support the view that cells have
diﬀerent tolerance levels for chronic hyperglycemia which may lead to
defective mitochondria that cannot properly respond to changes in
glucose levels, and this could lead to possible disruption in glucose
metabolism. HK-2 cells increased their basal ECAR in response to high
glucose, which may be a compensatory response to the condition when
cells cannot rely on their OXPHOS energy, but try to keep balance in
the cellular ATP production [36,47], or it could be caused by negative
regulation of the OXPHOS through glycolytic intermediates [48].
However, when the ratio of both OCR and ECAR were compared,
tubular cells seem to be metabolically less active in the presence of
hyperglycemia when compared to the mesangial cells after 1 week of
culture.
Energy production in the kidneys, which are mitochondrial rich
organs, is largely through respiration, and Warburg demonstrated that
the total energy production in quiescent kidney cells was similar to that
produced in proliferating cancer cells, which indicates how much
energy the kidney requires for proper functioning [49]. In support of
this, we found that after the heart, kidney has the second highest
mitochondrial DNA content when compared to other mouse organs,
including liver, blood, brain, islets and lungs [25] suggesting that
kidneys are rich in mitochondrial content. The data shown in the
current study clearly show that high glucose had a toxic eﬀect on renal
cell mitochondrial metabolism, but the mechanisms by which this was
caused remains unclear. Reserve capacity, described as a mitochondrial
bioenergetic reserve, was signiﬁcantly reduced in hyperglycemia in
both mesangial and tubular cells. Reserve capacity depends on many
factors, like substrate supply, energy demand and integrity of the
electron transport chain. Dysfunction in mitochondrial metabolism
could be caused by the direct eﬀect of the glucose through modiﬁcation
of mitochondria-localised proteins, as described by others [50–53]. But
it could also be caused by the disruption in the synthesis of mitochon-
drial complexes assembly subunits, caused by mutations in MtDNA.
We have previously detected a clear diﬀerence in metabolic function
between the patients with diabetes without and with DN and we have
shown that growth of renal cells in high glucose can rapidly change the
amount of MtDNA and cause MtDNA mutations, leading to the
proposal that the inability to cope with energy demand due to
MtDNA damage could be a key factor in the progression of DN [22].
If systemic mitochondrial dysfunction is associated with DN, then we
would predict systemic changes in the body which may be the basis of
renal microvascular complications in diabetes. In such a scenario,
diﬀerent cells in the body would show diﬀerent levels of sensitivity to
hyperglycemia induced damage, the extent of which would be related to
but not exclusive to mitochondrial content and bioenergetic need.
5. Conclusion
In conclusion, we have shown that hyperglycemia alters the
metabolic proﬁle of both mesangial and tubular cells by reducing their
mitochondrial respiratory function. Mesangial cells have a substantial
bioenergetic reserve compared to tubular cells. These results show that
distinct cells within one organ can have diﬀerent bioenergetic proﬁles
and sensitivities to hyperglycemia. A thorough understanding of the
bioenergetic properties of diﬀerent cell types to oxidative stress and
nutrient overload, present in diabetes and its complications is needed
and could lead to the development of novel therapies to protect
mitochondrial respiration in organs with high energy requirements.
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